Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026
Offer reference number: CM/TNS/25/5735
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months)
Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months)
Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Framework contract: £25,881,000 total value shared among 9 suppliers. Estimated equal shares shown below.
| Supplier | Identifier | Est. Share | Lots Won | Cross-References |
|---|---|---|---|---|
| ACCORD-UK LTD | 00079585 | ~£2,875,667 | 1 lot Lot 1 | - |
| AMAROX LIMITED | 10997632 | ~£2,875,667 | 1 lot Lot 1 | - |
| CELIX PHARMA LTD | 12474195 | ~£2,875,667 | 1 lot Lot 1 | - |
| DR REDDY'S LABORATORIES (UK) LIMITED | 01729064 | ~£2,875,667 | 1 lot Lot 1 | - |
| Farmak Pharmaceuticals UK Ltd | 15398948 | ~£2,875,667 | 1 lot Lot 1 | - |
| GLENMARK PHARMACEUTICALS EUROPE LIMITED | 05040260 | ~£2,875,667 | 1 lot Lot 1 | - |
| TEVA UK LIMITED | 00302461 | ~£2,875,667 | 1 lot Lot 1 | - |
| THORNTON & ROSS LIMITED | 00185947 | ~£2,875,667 | 1 lot Lot 1 | - |
| ZENTIVA PHARMA UK LIMITED | 02158996 | ~£2,875,667 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 18 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Feb 2026 – Sept 2027 | £37,954,000 £25,881,000 initial term | 18 | active |
Notices published under the Procurement Act 2023 name every bidder, including unsuccessful ones.
| Bidder | Bid on | Outcome |
|---|---|---|
| ACCORD-UK LTD | Lot 1 | Won |
| CELIX PHARMA LTD | Lot 1 | Won |
| DR REDDY'S LABORATORIES (UK) LIMITED | Lot 1 | Won |
| Farmak Pharmaceuticals UK Ltd | Lot 1 | Won |
| GLENMARK PHARMACEUTICALS EUROPE LIMITED | Lot 1 | Won |
| TEVA UK LIMITED | Lot 1 | Won |
| THORNTON & ROSS LIMITED | Lot 1 | Won |
| ZENTIVA PHARMA UK LIMITED | Lot 1 | Won |
Weightings from the notice.
Government spending data: These suppliers have received £96,622,149 in 264 payments (over £25k) from Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT, Maidstone and Tunbridge Wells NHS Trust, BEIS (2010-04-28 to 2026-03-12).